Pacira Pharmaceuticals (PCRX) Misses Q4 EPS Views; Guides FY11 Sales

March 31, 2011 6:38 AM

Pacira Pharmaceuticals (Nasdaq: PCRX) reported Q4 loss of $12.27, versus the analyst estimate of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found